Invesaro

Stocks SI Financial statements

Financial statements

SHOULDER INNOVATIONS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data SHOULDER INNOVATIONS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2025FY2025
Revenue31.647.3
Cost of revenue7.2811.1
Gross profit24.336.2
Research and development4.497.73
Selling, general and administrative34.554.8
Operating income-14.7-26.3
Interest expense1.320.07
Interest income0.771.95
Other non-operating income-0.97-14.1
Pre-tax income-15.6-40.4
Income tax00
Net income-15.6-40.4
EBITDA-12.8-23.4
EPS, basic-242.04-4.65
EPS, diluted-242.04-4.65
Shares, basic (weighted)0.068.67
Shares, diluted (weighted)0.068.67

Balance sheet

FY2025FY2025
Cash and equivalents6.1226.9
Short-term investments8.9297.4
Receivables5.128.27
Inventory1421.6
Other current assets0.571.48
Total current assets35.1157
Property, plant and equipment7.4912.5
Lease right-of-use assets0.070.11
Intangible assets0.40.1
Other non-current assets0
Total assets43.1170
Accounts payable4.868.87
Accrued liabilities2.745.26
Total current liabilities7.6514.2
Long-term debt14.714.9
Other non-current liabilities0.030.05
Total liabilities23.329.2
Total debt14.714.9
Paid-in capital2.15238
Retained earnings-57-97.4
Other comprehensive income0.20.12
Shareholders' equity-54.7141
Total equity-54.7141
Total liabilities and equity43.1170
Shares outstanding0.0820.6

Cash flow statement

FY2025FY2025
Net income-15.6-40.4
Depreciation and amortization1.92.91
Stock-based compensation0.751
Change in receivables-0.58-3.3
Change in inventory-4.03-7.64
Change in payables3.123.37
Cash from operations-14.1-28.6
Capital expenditures-4.02-7.41
Purchases of investments-5.28-119
Sales and maturities of investments23.331.3
Cash from investing14-95.6
Stock issued0.070.92
Cash from financing0.07145
Net change in cash-0.1120.7
Free cash flow-18.2-36
Interest paid1.791.69

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $21.93 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin77.8%Gross profit / revenue.
Operating margin-54.4%Operating income / revenue.
EBITDA margin-47.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-51.7%Pre-tax income / revenue.
Net margin-51.7%Net income / revenue.
FCF margin-66.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-54.2%Cash from operations / revenue.
Return on equity (ROE)-28.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-22.9%Net income / average total assets.
Return on invested capital (ROIC)-28.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue21.0%Research and development expense / revenue.
SG&A / revenue111.3%Selling, general and administrative expense / revenue.
Stock-based pay / revenue5.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue12.0%Capital expenditures / revenue.
D&A / revenue6.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y49.6%Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y48.7%Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y294.4%Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y13,340.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio10.7xCurrent assets / current liabilities.
Quick ratio8.28x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio7.52x(Cash + short-term investments) / current liabilities.
Debt / equity0.13xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets10.2%Total debt / total assets.
Liabilities / assets18.6%Total liabilities / total assets.
Net debt-$77.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$118.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.0%(Goodwill + intangible assets) / total assets.
Tangible book value$118.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.44xRevenue / average total assets.
Fixed asset turnover4.68xRevenue / average property, plant and equipment.
Inventory turnover0.59xCost of revenue / average inventory.
Days inventory622 days365 x average inventory / cost of revenue.
Receivables turnover6.94xRevenue / average receivables.
Days sales outstanding53 days365 x average receivables / revenue.
Days payables116 days365 x average accounts payable / cost of revenue.
Cash conversion cycle558 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.60Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$3.09Revenue / diluted weighted shares.
FCF per share-$2.05Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.68Cash from operations / diluted weighted shares.
Book value per share$5.66Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$5.66Tangible book value / shares outstanding.
Cash per share$4.41(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$456.6MShare price x shares outstanding.
Enterprise value$379.1MMarket cap + total debt - cash - short-term investments.
P/S7.08xMarket cap / revenue.
P/B3.86xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.86xMarket cap / tangible book value, when positive.
EV/Sales5.88xEnterprise value / revenue.
FCF yield-9.3%Free cash flow / market cap.
Earnings yield-7.3%Net income / market cap (the inverse of P/E).
What was SHOULDER INNOVATIONS, INC.'s revenue in fiscal 2025?

SHOULDER INNOVATIONS, INC. reported revenue of $47.3M for fiscal 2025, 49.6% higher than the year before.

Was SHOULDER INNOVATIONS, INC. profitable in fiscal 2025?

No. It reported a net loss of $40.4M.

How much free cash flow did SHOULDER INNOVATIONS, INC. generate in fiscal 2025?

Cash from operations of $28.6M minus capital expenditures of $7.4M left free cash flow of -$36.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SHOULDER INNOVATIONS, INC.